Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

NCT00029224

Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +31 more
Locations
  • Stockton Hematology Oncology Medical Group Stockton, California, United States
  • Osceola Cancer Center Kissimmee, Florida, United States
  • Nevada Cancer Center Las Vegas, Nevada, United States
  • Hematology-Oncology Associates PC Albuquerque, New Mexico, United States
View Trial Details
Completed

Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B

NCT01233440

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Study site Vienna, Austria
  • Study site Le Kremlin-Bicêtre, France
  • Study Site Lyon, France
  • Study site Nantes, France
View all 20 locations
View Trial Details
Completed

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

NCT00608907

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hematology Institute - Davidoff Center - Rabin Medical Center Petah Tikva, Israel
  • Divisione di Ematologia - Ospedale S Eugenio - P. le dell'Umanesimo Rome, Italy
  • Medical Academy - Dept of Hematology and Transplantology Gdansk, Poland
  • Klinika Nowotworow Ukladu - Chlonnego - Centrum Onkologii - Instytut Warsaw, Poland
View Trial Details
Completed

A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency

NCT00883090

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Study Site Dothan, Alabama, United States
  • Study Site Orange, California, United States
  • Study Site San Francisco, California, United States
  • Study Site Stockton, California, United States
View Trial Details
Completed

PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

NCT00048230

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • City of Hope Duarte, California, United States
  • Scripps Clinic La Jolla, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 93 locations
View Trial Details
Completed

A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039

NCT00063726

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Arkansas Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • City of Hope Duarte, California, United States
  • Scripps Clinic, Green Cancer Center La Jolla, California, United States
View all 76 locations
View Trial Details

Related conditions